Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy — PG-NAION

Ischemic Optic Neuropathy Clinical Trial

Official title:
Prospective, Unicentric, Randomized, Parallel, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate Intravenous Infusion of Prostaglandins as Therapy in Patients With Anterior Non-arteritic Ischemic Optic Neuropathy

Status Recruiting

Clinical Trial Summary

Correction of the deficit in the perfusion pressure of the microcirculation that supplies the nerve by intravenous infusion of Prostaglandin E1 (PGE1) (Alprostadil), expected to improve visual function in patients with ischemic optic neuropathy previous non-arteritic (NOIANA).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03851562
Study type	Interventional
Source	Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Contact	Rocio Hernandez Clares, MD
Phone	968 369473.
Email	rociohclares@hotmail.com
Status	Recruiting
Phase	Phase 2
Start date	June 13, 2018
Completion date	October 31, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02643615` - Safety and Efficacy of Using SightSaver Visual Evoked Potential (VEP) for VEP Monitoring in Prone Spine Surgery	N/A
Active, not recruiting	`NCT00000126` - Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)	N/A
Completed	`NCT00000127` - Ischemic Optic Neuropathy Decompression Trial (IONDT)	Phase 3
Recruiting	`NCT03475173` - New Non-invasive Modalities for Assessing Retinal Structure and Function	N/A
Completed	`NCT00450294` - Intraocular Pressure During Abdominal Aortic Aneurysm (AAA) Repair	N/A
Withdrawn	`NCT01607671` - Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%	Phase 1
Recruiting	`NCT05353413` - Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.	N/A
Recruiting	`NCT02377271` - ENDOTHELION Study Group: Effect of Bosentan in NAION Patients	Phase 3
Completed	`NCT01260324` - Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)